Treatment of agitation in terminally ill patients with intranasal midazolam versus subcutaneous midazolam: study protocol for a randomised controlled open-label monocentric trial (MinTU Study)

Table 3 Demographic data

Age
Gender
Weight and height
Nutritional status
Laboratory tests: liver and kidney
Distressing symptoms and underlying disease
Concomitant medications
Vital signs: pulse, respiration

ISSN: 1472-684X